- authorisedTherapeutic confirmatory (Phase III)
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced breast cancer (APTneo)
This study looks at new drug combinations for women with a certain type of aggressive breast cancer before surgery. It aims to see if these treatments can stop the cancer from coming back and improve long-term health, comparing their effects and safety.
Spain · Germany · Italy - active not recruitingNA
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
This study is looking into whether it's safe and effective to skip a second lymph node surgery in women with early breast cancer if their first lymph node test (sentinel node biopsy) shows some cancer cells.
France